John S Muchmore, MD - Medicare Endocrinology in Oklahoma City, OK

John S Muchmore, MD is a medicare enrolled "Internal Medicine - Endocrinology, Diabetes & Metabolism" physician in Oklahoma City, Oklahoma. He went to University Of Oklahoma College Of Medicine and graduated in 1975 and has 49 years of diverse experience with area of expertise as Endocrinology. He is a member of the group practice Integris Ambulatory Care Corporation and his current practice location is 5401 N Portland Ave Ste 410, Oklahoma City, Oklahoma. You can reach out to his office (for appointments etc.) via phone at (405) 945-4700.

John S Muchmore is licensed to practice in Oklahoma (license number 10850) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1033163100.

Contact Information

John S Muchmore, MD
5401 N Portland Ave Ste 410,
Oklahoma City, OK 73112-2131
(405) 945-4700
(405) 945-4270



Physician's Profile

Full NameJohn S Muchmore
GenderMale
SpecialityEndocrinology
Experience49 Years
Location5401 N Portland Ave Ste 410, Oklahoma City, Oklahoma
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • John S Muchmore attended and graduated from University Of Oklahoma College Of Medicine in 1975
  NPI Data:
  • NPI Number: 1033163100
  • Provider Enumeration Date: 05/21/2006
  • Last Update Date: 02/01/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 2860459336
  • Enrollment ID: I20041216000158

Medical Identifiers

Medical identifiers for John S Muchmore such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1033163100NPI-NPPES
100116630BMedicaidOK

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RE0101XInternal Medicine - Endocrinology, Diabetes & Metabolism 10850 (Oklahoma)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Integris Baptist Medical Center, IncOklahoma city, OKHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Integris Ambulatory Care Corporation2365408465382

News Archive

UMSOM research shows even milder cases of diarrheal diseases can lead to child mortality

Diarrheal diseases are a leading cause of death for young children, accounting for nine percent of all deaths worldwide in children under five years of age, with most occurring in children under two years of age.

RA patients more likely to experience hearing loss

RA is the commonest autoimmune arthritis affecting 1% of the general population. Despite its main articular manifestations, RA caninvolveextra-articular organs including the auditory system.

Researchers measure self-paced physical and cognitive activity to manage concussion

Concussion, a form of traumatic brain injury, is a common injury among children and teens. Concussions can have adverse effects on physical, cognitive, emotional and sleep health.

FDA grants Emergent Fast Track Designation for AVP-21D9 anthrax monoclonal antibody development program

Emergent BioSolutions Inc. announced today that its anthrax monoclonal antibody development program investigating AVP-21D9 for the treatment of inhalational anthrax has been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA). Emergent recently commenced a Phase I clinical trial for AVP-21D9, which is a fully human monoclonal antibody product candidate being developed as a parenteral post-exposure therapeutic to treat symptoms of inhalational anthrax disease.

BASF signs agreement to acquire Cognis for equity purchase price of euro 700 million

BASF SE has reached an agreement with Cognis Holding Luxembourg S.a r.l. controlled by Permira Funds, GS Capital Partners and SV Life Sciences to acquire the specialty chemicals company Cognis for an equity purchase price of euro 700 million. Including net financial debt and pension obligations, the enterprise value of the transaction is euro 3.1 billion. The acquisition is subject to clearance by the competent merger control authorities. Closing of the transaction is expected for November 2010 at the latest.

Read more Medical News

› Verified 8 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. John S Muchmore allows following entities to bill medicare on his behalf.
Entity NameIntegris Ambulatory Care Corporation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1750333936
PECOS PAC ID: 2365408465
Enrollment ID: O20041209000354

News Archive

UMSOM research shows even milder cases of diarrheal diseases can lead to child mortality

Diarrheal diseases are a leading cause of death for young children, accounting for nine percent of all deaths worldwide in children under five years of age, with most occurring in children under two years of age.

RA patients more likely to experience hearing loss

RA is the commonest autoimmune arthritis affecting 1% of the general population. Despite its main articular manifestations, RA caninvolveextra-articular organs including the auditory system.

Researchers measure self-paced physical and cognitive activity to manage concussion

Concussion, a form of traumatic brain injury, is a common injury among children and teens. Concussions can have adverse effects on physical, cognitive, emotional and sleep health.

FDA grants Emergent Fast Track Designation for AVP-21D9 anthrax monoclonal antibody development program

Emergent BioSolutions Inc. announced today that its anthrax monoclonal antibody development program investigating AVP-21D9 for the treatment of inhalational anthrax has been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA). Emergent recently commenced a Phase I clinical trial for AVP-21D9, which is a fully human monoclonal antibody product candidate being developed as a parenteral post-exposure therapeutic to treat symptoms of inhalational anthrax disease.

BASF signs agreement to acquire Cognis for equity purchase price of euro 700 million

BASF SE has reached an agreement with Cognis Holding Luxembourg S.a r.l. controlled by Permira Funds, GS Capital Partners and SV Life Sciences to acquire the specialty chemicals company Cognis for an equity purchase price of euro 700 million. Including net financial debt and pension obligations, the enterprise value of the transaction is euro 3.1 billion. The acquisition is subject to clearance by the competent merger control authorities. Closing of the transaction is expected for November 2010 at the latest.

Read more Medical News

› Verified 8 days ago

Entity NameIntegris Cardiovascular Physicians Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1306129598
PECOS PAC ID: 3577730068
Enrollment ID: O20120207000415

News Archive

UMSOM research shows even milder cases of diarrheal diseases can lead to child mortality

Diarrheal diseases are a leading cause of death for young children, accounting for nine percent of all deaths worldwide in children under five years of age, with most occurring in children under two years of age.

RA patients more likely to experience hearing loss

RA is the commonest autoimmune arthritis affecting 1% of the general population. Despite its main articular manifestations, RA caninvolveextra-articular organs including the auditory system.

Researchers measure self-paced physical and cognitive activity to manage concussion

Concussion, a form of traumatic brain injury, is a common injury among children and teens. Concussions can have adverse effects on physical, cognitive, emotional and sleep health.

FDA grants Emergent Fast Track Designation for AVP-21D9 anthrax monoclonal antibody development program

Emergent BioSolutions Inc. announced today that its anthrax monoclonal antibody development program investigating AVP-21D9 for the treatment of inhalational anthrax has been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA). Emergent recently commenced a Phase I clinical trial for AVP-21D9, which is a fully human monoclonal antibody product candidate being developed as a parenteral post-exposure therapeutic to treat symptoms of inhalational anthrax disease.

BASF signs agreement to acquire Cognis for equity purchase price of euro 700 million

BASF SE has reached an agreement with Cognis Holding Luxembourg S.a r.l. controlled by Permira Funds, GS Capital Partners and SV Life Sciences to acquire the specialty chemicals company Cognis for an equity purchase price of euro 700 million. Including net financial debt and pension obligations, the enterprise value of the transaction is euro 3.1 billion. The acquisition is subject to clearance by the competent merger control authorities. Closing of the transaction is expected for November 2010 at the latest.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. John S Muchmore is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
John S Muchmore, MD
5300 N Independence Ave, Suite 280,
Oklahoma City, OK 73112-5556

Ph: (405) 945-4700
John S Muchmore, MD
5401 N Portland Ave Ste 410,
Oklahoma City, OK 73112-2131

Ph: (405) 945-4700

News Archive

UMSOM research shows even milder cases of diarrheal diseases can lead to child mortality

Diarrheal diseases are a leading cause of death for young children, accounting for nine percent of all deaths worldwide in children under five years of age, with most occurring in children under two years of age.

RA patients more likely to experience hearing loss

RA is the commonest autoimmune arthritis affecting 1% of the general population. Despite its main articular manifestations, RA caninvolveextra-articular organs including the auditory system.

Researchers measure self-paced physical and cognitive activity to manage concussion

Concussion, a form of traumatic brain injury, is a common injury among children and teens. Concussions can have adverse effects on physical, cognitive, emotional and sleep health.

FDA grants Emergent Fast Track Designation for AVP-21D9 anthrax monoclonal antibody development program

Emergent BioSolutions Inc. announced today that its anthrax monoclonal antibody development program investigating AVP-21D9 for the treatment of inhalational anthrax has been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA). Emergent recently commenced a Phase I clinical trial for AVP-21D9, which is a fully human monoclonal antibody product candidate being developed as a parenteral post-exposure therapeutic to treat symptoms of inhalational anthrax disease.

BASF signs agreement to acquire Cognis for equity purchase price of euro 700 million

BASF SE has reached an agreement with Cognis Holding Luxembourg S.a r.l. controlled by Permira Funds, GS Capital Partners and SV Life Sciences to acquire the specialty chemicals company Cognis for an equity purchase price of euro 700 million. Including net financial debt and pension obligations, the enterprise value of the transaction is euro 3.1 billion. The acquisition is subject to clearance by the competent merger control authorities. Closing of the transaction is expected for November 2010 at the latest.

Read more News

› Verified 8 days ago


Internal Medicine Doctors in Oklahoma City, OK

Evelyn Lorents, MD
Endocrinology, Diabetes & Metabolism
Medicare: Accepting Medicare Assignments
Practice Location: 920 Sl Young Blvd, Oklahoma City, OK 73104
Phone: 405-271-5963    
Patrick Bronson Reeves, M.D.
Endocrinology, Diabetes & Metabolism
Medicare: Accepting Medicare Assignments
Practice Location: 3366 Nw Expressway Ste 550, Oklahoma City, OK 73112
Phone: 405-942-5442    Fax: 405-942-6448
Dr. Jake Lee Evans, MD
Endocrinology, Diabetes & Metabolism
Medicare: Not Enrolled in Medicare
Practice Location: 800 Stanton L Young Blvd, Aat 6300, Oklahoma City, OK 73104
Phone: 405-271-5963    
Metri Haddaden, MD
Endocrinology, Diabetes & Metabolism
Medicare: Medicare Enrolled
Practice Location: 800 Stanton L Young Blvd # 8425, Oklahoma City, OK 73104
Phone: 405-271-6173    Fax: 410-554-2184
Divya Sharma Divyadarshini, MD
Endocrinology, Diabetes & Metabolism
Medicare: Not Enrolled in Medicare
Practice Location: 800 Stanton L Young Blvd, Oklahoma City, OK 73104
Phone: 405-271-5963    
Dr. Philip Barton Miner, Jr., M.D.
Endocrinology, Diabetes & Metabolism
Medicare: Not Enrolled in Medicare
Practice Location: 1000 N Lincoln Blvd, Suite 210, Oklahoma City, OK 73104
Phone: 405-271-4644    Fax: 405-271-3296
Gary Lee Worcester, MD
Endocrinology, Diabetes & Metabolism
Medicare: Accepting Medicare Assignments
Practice Location: 3433 Nw 56th St, Ste 400, Oklahoma City, OK 73112
Phone: 405-947-3341    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.